Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies

Blood

Volumn 95, Issue 3, 2000, Pages 886-893

  Bergmeier, Wolfgang ^a   Rackebrandt, Kirsten ^a   Schröder, Werner ^a   Zirngibl, Hubert ^a   Nieswandt, Bernhard ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOCALICIN; MONOCLONAL ANTIBODY; PROTEINASE; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0034141860     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.3.886.003k45_886_893     Document Type: Article

References (48)

1. Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature. 1975;255:720.
2. Caen JP, Nurden AT, Jeanneau C, et al. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality: its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med. 1976;87:586.
3. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97.
4. Savage B, Saldivar E, Ruggeri ZM, Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289.
5. Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JE. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem. 1992;267:12,851.
6. Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem. 1992;267:364.
7. Jandrot-Perrus M, Bouton MC, Lanza F, Guillin MC. Thrombin interaction with platelet membrane glycoprotein Ib. Semin Thromb Hemost. 1996;22:151.
8. Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem. 1991;266:15,474.
9. Vicente V, Kostel PJ, Ruggeri ZM. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. J Biol Chem. 1988;263:18,473.
10. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med. 1984;311:1084.
11. Loscalzo J, Inbal A, Handin RI. von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest. 1986;78:1112.
12. Lankhof H, Wu YP, Vink T, et al. Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood. 1995;86:1035.
13. Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234.
14. Coller BS, Gralnick HR. Studies on the mechanism of ristocetin-induced platelet agglutination: effects of structural modification of ristocetin and vancomycin. J Clin Invest. 1977;60:302.
15. Read MS, Smith SV, Lamb MA, Brinkhous KM. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood. 1989;74:1031.
16. Hoylaerts MF. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Verh K Acad Geneeskd Belg. 1997;59:161.
17. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol. 1994;6:695.
18. Fujimoto T, Hawiger J. Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Nature. 1982;297:154.
19. Gralnick HR, Williams SB, Coller BS. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood. 1984;64:797.
20. Nurden A, Cazes E, Bihour C, et al. Confirmation that GP Ib-IX complexes have a reduced surface distribution on platelets activated by thrombin and TRAP-14-mer peptide. Br J Haematol. 1995;90:645.
21. Lu H, Menashi S, Garcia I, et al. Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function [see comments]. Br J Haematol. 1993;85:116.
22. Michelson AD, Benoit SE, Kroll MH, et al. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood. 1994;83:3562.
23. Fox JE. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinolysis. 1994;5:291.
24. White JG, Escolar G. Fate of the GPIb/IX receptor complex following activation of human platelets. Blood Coagul Fibrinolysis. 1996;7:262.
25. LaRosa CA, Rohrer MJ, Benoit SE, Barnard MR, Michelson AD. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the complex. Blood. 1994;84:158.
26. Wicki AN, Clemetson KJ. Structure and function of platelet membrane glycoproteins Ib and V: effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem. 1985;153:1.
27. Michelson AD, Loscalzo J, Melnick B, Coller BS, Handin RI. Partial characterization of a binding site tor von Willebrand factor on glycocalicin. Blood. 1986;67:19.
28. Nurden AT. Congenital abnormalities of platelet membrane glycoproteins. In: Kunicki TJ, George JN, eds. Platelet Immunobiology. Philadelphia: JB Lippincott; 1989:63.
29. Konkle BA, Shapiro SS, Asch AS, Nachman RL-.Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium. J Biol Chem. 1990; 265:19,833.
30. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA. Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells. Blood. 1992;80:153.
31. Wu G, Essex DW, Meloni FJ, et al. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood. 1997;90:2660.
32. Perrault C, Lankhof H, Pidard D, et al. Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor tor its interaction with endothelial cells. Blood. 1997;90:2335.
33. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 1998;101:479.
34. Rehli M, Krause SW, Kreutz M, Andreesen R. Carboxypeptidase M is identical to the MAX. 1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem. 1995;270:15,644.
35. Hirano T, Komatsu S, Tsunasawa H. Protein sequencing protocols. In: Smith BJ eds. Totowa, NJ: Human Press; 1997:287.
36. Ware J, Russell S, Ruggeri ZM. Cloning of the murine platelet glycoprotein Ibα gene highlighting species-specific platelet adhesion. Blood Cells Mol Dis. 1997;23:292.
37. McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res. 1996;32:752.
38. Beer JH, Buchi L, Steiner B. Glycocalicin: a new assay - the normal plasma levels and its potential usefulness in selected diseases. Blood. 1994;83:691.
39. Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor. Br J Pharmacol. 1997;122:165.
40. Becker BH, Miller JL: Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig. Blood. 1989;74:690.
41. Cadroy Y, Hanson SR, Kelly AB, et al. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood. 1994;83:3218.
42. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet. 1999;353:227.
43. Frojmovic MM. Platelet aggregation in flow: differential roles for adhesive receptors and ligands. Am Heart J. 1999;135(suppl):S119.
44. Asch AS, Adelman B, Fujimoto M, Nachman RL. Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells. J Clin Invest. 1988;81:1600.
45. Kelly MD, Essex DW, Shapiro SS, et al. Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ib beta (GPIb beta) and localization of the GPIb beta gene to chromosome 22 [see comments]. J Clin Invest. 1994;93:2417.
46. Beacham DA, Tran LP, Shapiro SS. Cytokine treatment of endothelial cells increases glycoprotein Ib alpha-dependent adhesion to von Willebrand factor. Blood. 1997;89:4071.
47. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin. and GPIbalpha. J Exp Med. 1998;187:329.
48. Fujita H, Hashimoto Y, Russell S, Zieger B, Ware J. In vivo expression of murine platelet glycoprotein Ibalpha. Blood. 1998;92:488.